Cash · 2011–2025
Supernus Pharmaceuticals cash
$128M+85.3% · FY2025
Supernus Pharmaceuticals (SUPN) reported $128M in cash for fiscal 2025, +85.3% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $128M | +85.3% | Open → |
| FY20242024-12-31 | $69.3M | −7.6% | Open → |
| FY20232023-12-31 | $75.1M | −19.4% | Open → |
| FY20222022-12-31 | $93.1M | −54.2% | Open → |
| FY20212021-12-31 | $203M | −29.5% | Open → |
| FY20202020-12-31 | $289M | +59.1% | Open → |
| FY20192019-12-31 | $181M | −5.7% | Open → |
| FY20182018-12-31 | $192M | +91.7% | Open → |
| FY20172017-12-31 | $100M | +51.1% | Open → |
| FY20162016-12-31 | $66.4M | +98.2% | Open → |
| FY20152015-12-31 | $33.5M | −8.0% | Open → |
| FY20142014-12-31 | $36.4M | +10.4% | Open → |
| FY20132013-12-31 | $33.0M | −18.2% | Open → |
| FY20122012-12-31 | $40.3M | −17.0% | Open → |
| FY20112011-12-31 | $48.5M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +7.2%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Supernus Pharmaceuticals cash |url=https://companiesranked.com/en/company/supernus-pharmaceuticals/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Supernus Pharmaceuticals cash. CompaniesRanked. https://companiesranked.com/en/company/supernus-pharmaceuticals/cash-on-handBibTeX
@misc{companiesranked-en-company-supernus-pharmaceuticals-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Supernus Pharmaceuticals cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/supernus-pharmaceuticals/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001356576-26-000037 · August 3, 2026
{{cite web |title=Supernus Pharmaceuticals cash — 10-Q (0001356576-26-000037) |url=https://www.sec.gov/Archives/edgar/data/1356576/000135657626000037/supn-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-03}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.